X

Branded Drug

Lupin Ltd Q1FY25; 78% rise in Profits

Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai. Lupin develops and commercializes a wide range of branded and…

Sanofi India Ltd Q1FY25; 16% fall in Profits

Sanofi India Limited is amongst the leading multinational companies in the Indian Pharmaceutical Market. It offers a wide array of…

Unichem Laboratories Ltd Q4FY24; 7% rise in Revenue

Unichem Laboratories Ltd is involved in pharmaceuticals in Generics, APIs and Contract Manufacturing (CMO) areas. Financial Results: Unichem Laboratories Ltd…

Suven Pharmaceuticals Ltd Q4FY24; 57% fall in Profits

Hyderabad based CDMO company that offers services to leading global pharmaceutical and fine chemical majors in their NCE development endeavours.…

Sun Pharmaceuticals Industries Ltd Q4FY24; 34% rise in Profits

Sun Pharmaceutical Industries Ltd is engaged in the business of manufacturing, developing and marketing a wide range of branded and…

Sun Pharma Advanced Research Company Ltd Q4FY24; 65% fall in Revenue

Sun Pharma Advanced Research Company Ltd is engaged in the business of research and development (R&D) of pharmaceutical products. Financial…

Procter & Gamble Health Ltd Q4FY24; 20% fall in Profits

P&G Health Ltd (formerly Procter & Gamble td) (erstwhile Merck Limited) is engaged in the business of manufacturing and marketing…

Piramal Pharma Ltd Q4FY24; 102% rise in Profits

Piramal Pharma Limited (PPL) is part of the Piramal group of companies. The company operates through 3 major segments(1) Contract…

Pfizer Ltd Q4FY24; 38% rise in Profits

Pfizer Ltd is engaged in manufacturing, marketing, trading and export of pharmaceutical products. It manufactures products through its own facility…

Torrent Pharmaceuticals Ltd Q3FY24; 52% rise in Profits

Torrent Pharmaceuticals Ltd is one of the leading Indian Pharmaceutical Company engaged in research, development, manufacturing and marketing of generic…

Shilpa Medicare Ltd Q3FY24; 9% rise in Revenue

Shilpa Medicare is engaged in the business of high quality Active Pharmaceuticals Ingredients (APIs), Intermediates, Formulations, New Drug delivery system,…

Sanofi India Ltd Q3FY24; 5% rise in Profits

Sanofi India is engaged in Business of Manufacture and sale of pharmaceutical products. Financial Results: Sanofi India Ltd reported Revenues…

Pfizer Ltd Q3FY24; 14% fall in Profits

Pfizer Ltd is engaged in manufacturing, marketing, trading and export of pharmaceutical products. It manufactures products through its own facility…

Marksans Pharma Ltd Q3FY24; 34% rise in Profits

Marksans Pharma is engaged in the Business of Formulation of pharmaceutical products. Financial Results: Marksans Pharma Ltd reported Revenues for…

Divi’s Laboratories Ltd Q3 FY24 Earnings Conference Call Insights

Key highlights from Divi's Laboratories Ltd (DIVISLAB) Q3 FY24 Earnings Concall Growth and Performance Witnessed a steady 3Q driven by…

Sun Pharmaceuticals Industries Ltd Q3FY24; 17% rise in Profits

Sun Pharmaceutical Industries Ltd is engaged in the business of manufacturing, developing and marketing a wide range of branded and…

Divi’s Laboratories Ltd Q2 FY24 Earnings Conference Call Insights

Key highlights from Divi's Laboratories Ltd (DIVISLAB) Q2 FY24 Earnings Concall Business Overview Anticipating growth opportunities in contrast media, sartans,…

Divi’s Laboratories Ltd Q4 FY23 Earnings Conference Call Insights

Key highlights from Divi's Laboratories Ltd (DIVISLAB) Q4 FY23 Earnings Concall Q&A Highlights: [00:11:30] Tushar Manudhane from Motilal Oswal asked…

Torrent pharma Q3FY23 net profit rises by 14 percent

Torrent Pharma reported that its consolidated net profit increased by 14 per cent to INR 283 crore in the third…

Zydus lifescience net profit soars by 23% in Q3FY23

Zydus Lifesciences Ltd reported a 23 per cent rise in consolidated net profit at INR 631 crore for the third…

Zydus Lifesciences Q3FY23 net profit rises by 23%; Revenue soars 20%

Zydus Lifesciences Ltd reported a 23 per cent rise in consolidated net profit at INR 631 crore for the third…